Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COPITCH: Consequences of Oedema on the Prognosis of InTraCerebral Haemorrhage
NCT04621357Recruiting
- Sponsor
- CHU de Lille
- Start
- Jun 2021
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
Single-arm trial, sponsored by CHU de Lille. Primary endpoint: Poor functional outcome defined as a modified Rankin Scale of 4 or more at 3 months. Started Jun 2021; status: recruiting.
Beyond the preview
Go deeper on NCT04621357.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04621357.